Bingzhi Zhang
- LATE-BREAKING ABSTRACT: A dose-ranging study of dupilumab in patients (pts) with uncontrolled asthma despite use of inhaled corticosteroids plus a long-acting beta-agonist (ICS/LABA): Final dataBy Sally Wenzel, Mario Castro, Bingzhi Zhang, Gianluca Pirozzi, E. Rand Sutherland, Neil Graham, Robert R. Evans, Mariana Louis-Tisserand and Ariel TeperSally Wenzel1Division of Pulmonary Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA United StatesMario Castro2Division of Pulmonary and Critical Care Medicine, Washington University School of Medicine, Saint Louis, MO United StatesBingzhi Zhang3Research and Development, Sanofi, Bridgewater, NJ United StatesGianluca Pirozzi3Research and Development, Sanofi, Bridgewater, NJ United StatesE. Rand Sutherland3Research and Development, Sanofi, Bridgewater, NJ United StatesNeil Graham4Medical Affairs, Regeneron Pharmaceuticals Inc., Tarrytown, NY United StatesRobert R. Evans4Medical Affairs, Regeneron Pharmaceuticals Inc., Tarrytown, NY United StatesMariana Louis-Tisserand3Research and Development, Sanofi, Bridgewater, NJ United StatesAriel Teper3Research and Development, Sanofi, Bridgewater, NJ United States
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.